Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: Results from a multi-centre case–control study in Europe

Cassidy, Adrian; Balsan, Jessica; Vesin, Aurélien; Wu, Xifeng; Liloglou, Triantafillos; Brambilla, Christian; Timsit, Jean-François; Field, John K.; EUELC Consortium,

doi:10.1016/j.ejca.2009.05.006

« Previous Next »European Journal of Cancer
Volume 45, Issue 17 , Pages 3047-3053, November 2009

Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: Results from a multi-centre case–control study in Europe

Adrian Cassidy
- Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom
- Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
- These authors contributed equally to this work.
Jessica Balsan
- INSERM U823, Institut Albert Bonniot, Team 11: “Outcome of cancer and critical illnesses”, Grenoble, France
- These authors contributed equally to this work.
Aurélien Vesin
- INSERM U823, Institut Albert Bonniot, Team 11: “Outcome of cancer and critical illnesses”, Grenoble, France
Xifeng Wu
- Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States
Triantafillos Liloglou
- Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom
Christian Brambilla
- Institut Albert Bonniot, Université Joseph Fourier, INSERM U823; Grenoble, France
Jean-François Timsit
- INSERM U823, Institut Albert Bonniot, Team 11: “Outcome of cancer and critical illnesses”, Grenoble, France
- Corresponding authors: Fax: +44 151 794 8999 (J.K. Field), +33 04 76 76 55 69 (J.-F. Timsit).
John K. Field
- Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom
- Corresponding authors: Fax: +44 151 794 8999 (J.K. Field), +33 04 76 76 55 69 (J.-F. Timsit).
EUELC Consortium
- European Early Lung Cancer (EUELC) Consortium: Christian Brambilla, Institut Albert Bonniot; Université Joseph Fourier; INSERM U823;Grenoble, France; Yves Martinet, Centre Hospitalier Universitaire de Nancy, France; Frederik B. Thunnissen, Department of Pathology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands and Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands; Peter J. Snijders, Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands; Gabriella Sozzi, Department of Experimental Oncology and Laboratories, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy; Angela Risch, German Cancer Research Centre, Heidelberg, Germany; Heinrich D. Becker, Thoraxklinik at Heidelberg University, Heidelberg, Germany; J. Stuart Elborn, Respiratory Medicine Research Group, Centre for Infection and Immunity, Queen’s University, Belfast, United Kingdom; Nicholas D. Magee, Respiratory Medicine Research Group, Centre for Infection and Immunity, Queen’s University, Belfast, United Kingdom; Luis M. Montuenga, Center for Applied Medical Research (CIMA), University of Navarra, Spain; Ken J. O’Byrne, St. James Hospital, Dublin, Ireland; David J. Harrison, University of Edinburgh, Edinburgh, United Kingdom; Jacek Niklinski, Medical Academy of Bialystok, Bialystok, Poland; John K. Field Roy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom.